Production (Stage)
NanoSphere Health Sciences Inc.
NSHS
CNSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -2.16% | -18.93% | -35.72% | -25.38% | -21.50% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -8.68% | -23.27% | -33.17% | -21.51% | -20.83% |
| Operating Income | 8.68% | 23.27% | 33.17% | 21.51% | 20.83% |
| Income Before Tax | 196.06% | 215.38% | 25.41% | 23.69% | 18.65% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 196.06% | 215.38% | 25.41% | 23.69% | 18.65% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 196.06% | 215.38% | 25.41% | 23.69% | 18.65% |
| EBIT | 8.68% | 23.27% | 33.17% | 21.51% | 20.83% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 196.65% | 216.29% | 25.48% | 24.11% | 18.99% |
| Normalized Basic EPS | -36.64% | -4.32% | 26.38% | 24.53% | 19.14% |
| EPS Diluted | 196.65% | 216.29% | 25.48% | 24.11% | 18.99% |
| Normalized Diluted EPS | -36.64% | -4.32% | 26.38% | 24.53% | 19.14% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |